Cargando…
Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression
Despite the increasing incidence of endometrial cancer (EC) worldwide and the poor overall survival of patients who recur, no reliable biomarker exists for detecting and monitoring EC recurrence and progression during routine follow-up. Circulating tumor DNA (ctDNA) is a sensitive method for monitor...
Autores principales: | Moss, Esther L., Gorsia, Diviya N., Collins, Anna, Sandhu, Pavandeep, Foreman, Nalini, Gore, Anupama, Wood, Joey, Kent, Christopher, Silcock, Lee, Guttery, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463944/ https://www.ncbi.nlm.nih.gov/pubmed/32785174 http://dx.doi.org/10.3390/cancers12082231 |
Ejemplares similares
-
Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas
por: Guttery, David S., et al.
Publicado: (2018) -
Differences in the molecular profile of endometrial cancers from British White and British South Asian women
por: Polymeros, Konstantinos, et al.
Publicado: (2020) -
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2022) -
Case series of outcomes in advanced cancer patients with single pathway alterations receiving N-of-One therapies
por: Gupta, Diviya, et al.
Publicado: (2022) -
Endometrial receptivity array: Clinical application
por: Mahajan, Nalini
Publicado: (2015)